MedPath

A Pilot Study to Explore the Role of Gut Flora in Chronic Constipation

Withdrawn
Conditions
Constipation Chronic Idiopathic
Constipation (Excl Faecal Impaction)
Constipation
Constipation - Functional
Registration Number
NCT04148248
Lead Sponsor
ProgenaBiome
Brief Summary

This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records regarding chronic constipation

Detailed Description

The goal of this Research Study is to better understand how the genetic information in subject's microbiome correlates to the information provided in surveys and in medical records regarding chronic constipation.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  1. Signed informed consent, demonstrating that the patient understands the procedures required for the study and the purpose of the study
  2. Male or female patients of any age (interest is given to children to compare with mothers)
  3. Diagnosis of chronic constipation
Exclusion Criteria
  1. Refusal to sign informed consent form
  2. History of bariatric surgery, total colectomy with ileorectal anastomosis or proctocolectomy.
  3. Postoperative stoma, ostomy, or ileoanal pouch
  4. Participation in any experimental drug protocol within the past 12 weeks
  5. Treatment with total parenteral nutrition
  6. Any clinically significant evidence of disease that could interfere with the subject's ability to enter the trial
  7. Inability to adequately communicate with the investigator or their respective designee and/or comply with the requirements of the entire study

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Correlation of Microbiome to Disease via Relative Abundance Found in Microbiome SequencingOne year

Relative abundance of bacterial classes within taxonomic phyla and, more broadly, within their domain will be analyzed by sequencing the gut microbiome. These data will then be categorized among specific gastrointestinal disease types.

Secondary Outcome Measures
NameTimeMethod
Validation of Sequencing MethodsOne year

To validate the methods used to sequence samples

Trial Locations

Locations (1)

ProgenaBiome

🇺🇸

Ventura, California, United States

ProgenaBiome
🇺🇸Ventura, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.